NEW YORK (Reuters Health) – Ovarian- and uterine-conserving surgery appears to be safe in premenopausal women with stage IA or IC epithelial ovarian cancer, with no adverse impact…
NEW YORK (Reuters Health) – Cardiac troponin-I is superior to electrocardiogram and creatinine kinase MB for predicting myocardial injury after coronary artery bypass graft (CABG) surgery, results of…
NEW YORK (Reuters Health) – As first-line therapy for advanced chronic lymphocytic leukemia, bendamustine produced significantly higher response rates and longer progression-free survival than chlorambucil in a phase…
NEW YORK (Reuters Health) – Both progression-free and overall survival are extended in patients with advanced non-small cell lung cancer treated with erlotinib following standard chemotherapy, according to…
NEW YORK (Reuters Health) – Due to hemoglobin degradation, delayed return of fecal occult blood tests (FOBTs) may miss colorectal adenomas and possibly also overt malignancy, according to…
NEW YORK (Reuters Health) – INR testing intervals of 4 weeks or less are typically recommended for patients on long-term warfarin therapy, but new research suggests that less…
NEW YORK (Reuters Health) – Allogeneic blood transfusions in patients who undergo coronary artery bypass graft surgery (CABG) substantially increase the patient’s odds of nosocomial infection, hospital readmission…
NEW YORK (Reuters Health) – Lung volume reduction surgery extends survival in patients with advanced emphysema and also improves quality of life, new research confirms. “We found lung…
NEW YORK (Reuters Health) – Patients hospitalized for acute coronary syndrome (ACS) are less likely to survive until discharge if they have a known history of prior atherosclerosis,…
NEW YORK (Reuters Health) – A single question may be all it takes for primary care providers to accurately screen patients who may be drinking too much, new…